Global Adeno-Associated Virus Vectors in Gene Therapy Supply, Demand and Key Producers, 2023-2029
Page: 108
Published Date: 20 Mar 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags
Description
The global Adeno-Associated Virus Vectors in Gene Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which in turn belongs to the family Parvoviridae. They are small (20 nm) replication-defective, nonenveloped viruses and have linear single-stranded DNA (ssDNA) genome of approximately 4.8 kilobases (kb).
This report studies the global Adeno-Associated Virus Vectors in Gene Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adeno-Associated Virus Vectors in Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adeno-Associated Virus Vectors in Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adeno-Associated Virus Vectors in Gene Therapy total production and demand, 2018-2029, (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy total production value, 2018-2029, (USD Million)
Global Adeno-Associated Virus Vectors in Gene Therapy production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy consumption by region & country, CAGR, 2018-2029 & (Kg)
U.S. VS China: Adeno-Associated Virus Vectors in Gene Therapy domestic production, consumption, key domestic manufacturers and share
Global Adeno-Associated Virus Vectors in Gene Therapy production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Kg)
Global Adeno-Associated Virus Vectors in Gene Therapy production by Application production, value, CAGR, 2018-2029, (USD Million) & (Kg)
This reports profiles key players in the global Adeno-Associated Virus Vectors in Gene Therapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amicus Therapeutics, Asklepios Biopharmaceutical, BioMarin Pharmaceutical, Coave Therapeutics, MeiraGTx, Neurocrine Biosciences, Pfizer, Roche Holding and Sangamo Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adeno-Associated Virus Vectors in Gene Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kg) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adeno-Associated Virus Vectors in Gene Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Adeno-Associated Virus Vectors in Gene Therapy Market, Segmentation by Type
Serotype 2 (AVV 2)
Synthetic Serotypes
Others
Global Adeno-Associated Virus Vectors in Gene Therapy Market, Segmentation by Application
Alzheimer's Disease
Cystic Dibrosis
Hemophilia B
Parkinson's Disease
Companies Profiled:
Amicus Therapeutics
Asklepios Biopharmaceutical
BioMarin Pharmaceutical
Coave Therapeutics
MeiraGTx
Neurocrine Biosciences
Pfizer
Roche Holding
Sangamo Therapeutics
Sarepta Therapeutics
Spark Therapeutics
Voyager Therapeutics
NightstaRx
Key Questions Answered
1. How big is the global Adeno-Associated Virus Vectors in Gene Therapy market?
2. What is the demand of the global Adeno-Associated Virus Vectors in Gene Therapy market?
3. What is the year over year growth of the global Adeno-Associated Virus Vectors in Gene Therapy market?
4. What is the production and production value of the global Adeno-Associated Virus Vectors in Gene Therapy market?
5. Who are the key producers in the global Adeno-Associated Virus Vectors in Gene Therapy market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Adeno-Associated Virus Vectors in Gene Therapy Introduction
1.2 World Adeno-Associated Virus Vectors in Gene Therapy Supply & Forecast
1.2.1 World Adeno-Associated Virus Vectors in Gene Therapy Production Value (2018 & 2022 & 2029)
1.2.2 World Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029)
1.2.3 World Adeno-Associated Virus Vectors in Gene Therapy Pricing Trends (2018-2029)
1.3 World Adeno-Associated Virus Vectors in Gene Therapy Production by Region (Based on Production Site)
1.3.1 World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Region (2018-2029)
1.3.2 World Adeno-Associated Virus Vectors in Gene Therapy Production by Region (2018-2029)
1.3.3 World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2018-2029)
1.3.4 North America Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029)
1.3.5 Europe Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029)
1.3.6 China Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029)
1.3.7 Japan Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adeno-Associated Virus Vectors in Gene Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Adeno-Associated Virus Vectors in Gene Therapy Demand (2018-2029)
2.2 World Adeno-Associated Virus Vectors in Gene Therapy Consumption by Region
2.2.1 World Adeno-Associated Virus Vectors in Gene Therapy Consumption by Region (2018-2023)
2.2.2 World Adeno-Associated Virus Vectors in Gene Therapy Consumption Forecast by Region (2024-2029)
2.3 United States Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
2.4 China Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
2.5 Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
2.6 Japan Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
2.7 South Korea Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
2.8 ASEAN Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
2.9 India Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029)
3.1 World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Manufacturer (2018-2023)
3.2 World Adeno-Associated Virus Vectors in Gene Therapy Production by Manufacturer (2018-2023)
3.3 World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Manufacturer (2018-2023)
3.4 Adeno-Associated Virus Vectors in Gene Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adeno-Associated Virus Vectors in Gene Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adeno-Associated Virus Vectors in Gene Therapy in 2022
3.5.3 Global Concentration Ratios (CR8) for Adeno-Associated Virus Vectors in Gene Therapy in 2022
3.6 Adeno-Associated Virus Vectors in Gene Therapy Market: Overall Company Footprint Analysis
3.6.1 Adeno-Associated Virus Vectors in Gene Therapy Market: Region Footprint
3.6.2 Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Type Footprint
3.6.3 Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Value Comparison
4.1.1 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Comparison
4.2.1 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Consumption Comparison
4.3.1 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2023)
4.5 China Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers and Market Share
4.5.1 China Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value (2018-2023)
4.5.3 China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2023)
4.6 Rest of World Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2023)
5.1 World Adeno-Associated Virus Vectors in Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Serotype 2 (AVV 2)
5.2.2 Synthetic Serotypes
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Adeno-Associated Virus Vectors in Gene Therapy Production by Type (2018-2029)
5.3.2 World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Type (2018-2029)
5.3.3 World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2029)
6.1 World Adeno-Associated Virus Vectors in Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Alzheimer's Disease
6.2.2 Cystic Dibrosis
6.2.3 Hemophilia B
6.2.4 Parkinson's Disease
6.3 Market Segment by Application
6.3.1 World Adeno-Associated Virus Vectors in Gene Therapy Production by Application (2018-2029)
6.3.2 World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Application (2018-2029)
6.3.3 World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2029)
7.1 Amicus Therapeutics
7.1.1 Amicus Therapeutics Details
7.1.2 Amicus Therapeutics Major Business
7.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Amicus Therapeutics Recent Developments/Updates
7.1.6 Amicus Therapeutics Competitive Strengths & Weaknesses
7.2 Asklepios Biopharmaceutical
7.2.1 Asklepios Biopharmaceutical Details
7.2.2 Asklepios Biopharmaceutical Major Business
7.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Asklepios Biopharmaceutical Recent Developments/Updates
7.2.6 Asklepios Biopharmaceutical Competitive Strengths & Weaknesses
7.3 BioMarin Pharmaceutical
7.3.1 BioMarin Pharmaceutical Details
7.3.2 BioMarin Pharmaceutical Major Business
7.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BioMarin Pharmaceutical Recent Developments/Updates
7.3.6 BioMarin Pharmaceutical Competitive Strengths & Weaknesses
7.4 Coave Therapeutics
7.4.1 Coave Therapeutics Details
7.4.2 Coave Therapeutics Major Business
7.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Coave Therapeutics Recent Developments/Updates
7.4.6 Coave Therapeutics Competitive Strengths & Weaknesses
7.5 MeiraGTx
7.5.1 MeiraGTx Details
7.5.2 MeiraGTx Major Business
7.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 MeiraGTx Recent Developments/Updates
7.5.6 MeiraGTx Competitive Strengths & Weaknesses
7.6 Neurocrine Biosciences
7.6.1 Neurocrine Biosciences Details
7.6.2 Neurocrine Biosciences Major Business
7.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Neurocrine Biosciences Recent Developments/Updates
7.6.6 Neurocrine Biosciences Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Roche Holding
7.8.1 Roche Holding Details
7.8.2 Roche Holding Major Business
7.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Roche Holding Recent Developments/Updates
7.8.6 Roche Holding Competitive Strengths & Weaknesses
7.9 Sangamo Therapeutics
7.9.1 Sangamo Therapeutics Details
7.9.2 Sangamo Therapeutics Major Business
7.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Sangamo Therapeutics Recent Developments/Updates
7.9.6 Sangamo Therapeutics Competitive Strengths & Weaknesses
7.10 Sarepta Therapeutics
7.10.1 Sarepta Therapeutics Details
7.10.2 Sarepta Therapeutics Major Business
7.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sarepta Therapeutics Recent Developments/Updates
7.10.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
7.11 Spark Therapeutics
7.11.1 Spark Therapeutics Details
7.11.2 Spark Therapeutics Major Business
7.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Spark Therapeutics Recent Developments/Updates
7.11.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.12 Voyager Therapeutics
7.12.1 Voyager Therapeutics Details
7.12.2 Voyager Therapeutics Major Business
7.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Voyager Therapeutics Recent Developments/Updates
7.12.6 Voyager Therapeutics Competitive Strengths & Weaknesses
7.13 NightstaRx
7.13.1 NightstaRx Details
7.13.2 NightstaRx Major Business
7.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
7.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 NightstaRx Recent Developments/Updates
7.13.6 NightstaRx Competitive Strengths & Weaknesses
8.1 Adeno-Associated Virus Vectors in Gene Therapy Industry Chain
8.2 Adeno-Associated Virus Vectors in Gene Therapy Upstream Analysis
8.2.1 Adeno-Associated Virus Vectors in Gene Therapy Core Raw Materials
8.2.2 Main Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adeno-Associated Virus Vectors in Gene Therapy Production Mode
8.6 Adeno-Associated Virus Vectors in Gene Therapy Procurement Model
8.7 Adeno-Associated Virus Vectors in Gene Therapy Industry Sales Model and Sales Channels
8.7.1 Adeno-Associated Virus Vectors in Gene Therapy Sales Model
8.7.2 Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Region (2018-2023)
Table 5. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Region (2024-2029)
Table 6. World Adeno-Associated Virus Vectors in Gene Therapy Production by Region (2018-2023) & (Kg)
Table 7. World Adeno-Associated Virus Vectors in Gene Therapy Production by Region (2024-2029) & (Kg)
Table 8. World Adeno-Associated Virus Vectors in Gene Therapy Production Market Share by Region (2018-2023)
Table 9. World Adeno-Associated Virus Vectors in Gene Therapy Production Market Share by Region (2024-2029)
Table 10. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2018-2023) & (US$/Kg)
Table 11. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Region (2024-2029) & (US$/Kg)
Table 12. Adeno-Associated Virus Vectors in Gene Therapy Major Market Trends
Table 13. World Adeno-Associated Virus Vectors in Gene Therapy Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Kg)
Table 14. World Adeno-Associated Virus Vectors in Gene Therapy Consumption by Region (2018-2023) & (Kg)
Table 15. World Adeno-Associated Virus Vectors in Gene Therapy Consumption Forecast by Region (2024-2029) & (Kg)
Table 16. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adeno-Associated Virus Vectors in Gene Therapy Producers in 2022
Table 18. World Adeno-Associated Virus Vectors in Gene Therapy Production by Manufacturer (2018-2023) & (Kg)
Table 19. Production Market Share of Key Adeno-Associated Virus Vectors in Gene Therapy Producers in 2022
Table 20. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 21. Global Adeno-Associated Virus Vectors in Gene Therapy Company Evaluation Quadrant
Table 22. World Adeno-Associated Virus Vectors in Gene Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adeno-Associated Virus Vectors in Gene Therapy Production Site of Key Manufacturer
Table 24. Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Type Footprint
Table 25. Adeno-Associated Virus Vectors in Gene Therapy Market: Company Product Application Footprint
Table 26. Adeno-Associated Virus Vectors in Gene Therapy Competitive Factors
Table 27. Adeno-Associated Virus Vectors in Gene Therapy New Entrant and Capacity Expansion Plans
Table 28. Adeno-Associated Virus Vectors in Gene Therapy Mergers & Acquisitions Activity
Table 29. United States VS China Adeno-Associated Virus Vectors in Gene Therapy Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adeno-Associated Virus Vectors in Gene Therapy Production Comparison, (2018 & 2022 & 2029) & (Kg)
Table 31. United States VS China Adeno-Associated Virus Vectors in Gene Therapy Consumption Comparison, (2018 & 2022 & 2029) & (Kg)
Table 32. United States Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2023) & (Kg)
Table 36. United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Market Share (2018-2023)
Table 37. China Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2023) & (Kg)
Table 41. China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Market Share (2018-2023)
Table 42. Rest of World Based Adeno-Associated Virus Vectors in Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2023) & (Kg)
Table 46. Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Market Share (2018-2023)
Table 47. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adeno-Associated Virus Vectors in Gene Therapy Production by Type (2018-2023) & (Kg)
Table 49. World Adeno-Associated Virus Vectors in Gene Therapy Production by Type (2024-2029) & (Kg)
Table 50. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2023) & (US$/Kg)
Table 53. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2024-2029) & (US$/Kg)
Table 54. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adeno-Associated Virus Vectors in Gene Therapy Production by Application (2018-2023) & (Kg)
Table 56. World Adeno-Associated Virus Vectors in Gene Therapy Production by Application (2024-2029) & (Kg)
Table 57. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2023) & (US$/Kg)
Table 60. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2024-2029) & (US$/Kg)
Table 61. Amicus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Amicus Therapeutics Major Business
Table 63. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 64. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Amicus Therapeutics Recent Developments/Updates
Table 66. Amicus Therapeutics Competitive Strengths & Weaknesses
Table 67. Asklepios Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Asklepios Biopharmaceutical Major Business
Table 69. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 70. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Asklepios Biopharmaceutical Recent Developments/Updates
Table 72. Asklepios Biopharmaceutical Competitive Strengths & Weaknesses
Table 73. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. BioMarin Pharmaceutical Major Business
Table 75. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 76. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BioMarin Pharmaceutical Recent Developments/Updates
Table 78. BioMarin Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Coave Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Coave Therapeutics Major Business
Table 81. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 82. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Coave Therapeutics Recent Developments/Updates
Table 84. Coave Therapeutics Competitive Strengths & Weaknesses
Table 85. MeiraGTx Basic Information, Manufacturing Base and Competitors
Table 86. MeiraGTx Major Business
Table 87. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 88. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. MeiraGTx Recent Developments/Updates
Table 90. MeiraGTx Competitive Strengths & Weaknesses
Table 91. Neurocrine Biosciences Basic Information, Manufacturing Base and Competitors
Table 92. Neurocrine Biosciences Major Business
Table 93. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 94. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Neurocrine Biosciences Recent Developments/Updates
Table 96. Neurocrine Biosciences Competitive Strengths & Weaknesses
Table 97. Pfizer Basic Information, Manufacturing Base and Competitors
Table 98. Pfizer Major Business
Table 99. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 100. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Pfizer Recent Developments/Updates
Table 102. Pfizer Competitive Strengths & Weaknesses
Table 103. Roche Holding Basic Information, Manufacturing Base and Competitors
Table 104. Roche Holding Major Business
Table 105. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 106. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Roche Holding Recent Developments/Updates
Table 108. Roche Holding Competitive Strengths & Weaknesses
Table 109. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 110. Sangamo Therapeutics Major Business
Table 111. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 112. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Sangamo Therapeutics Recent Developments/Updates
Table 114. Sangamo Therapeutics Competitive Strengths & Weaknesses
Table 115. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 116. Sarepta Therapeutics Major Business
Table 117. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 118. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sarepta Therapeutics Recent Developments/Updates
Table 120. Sarepta Therapeutics Competitive Strengths & Weaknesses
Table 121. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 122. Spark Therapeutics Major Business
Table 123. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 124. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Spark Therapeutics Recent Developments/Updates
Table 126. Spark Therapeutics Competitive Strengths & Weaknesses
Table 127. Voyager Therapeutics Basic Information, Manufacturing Base and Competitors
Table 128. Voyager Therapeutics Major Business
Table 129. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 130. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Voyager Therapeutics Recent Developments/Updates
Table 132. NightstaRx Basic Information, Manufacturing Base and Competitors
Table 133. NightstaRx Major Business
Table 134. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product and Services
Table 135. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Adeno-Associated Virus Vectors in Gene Therapy Upstream (Raw Materials)
Table 137. Adeno-Associated Virus Vectors in Gene Therapy Typical Customers
Table 138. Adeno-Associated Virus Vectors in Gene Therapy Typical Distributors
List of Figure
Figure 1. Adeno-Associated Virus Vectors in Gene Therapy Picture
Figure 2. World Adeno-Associated Virus Vectors in Gene Therapy Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adeno-Associated Virus Vectors in Gene Therapy Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029) & (Kg)
Figure 5. World Adeno-Associated Virus Vectors in Gene Therapy Average Price (2018-2029) & (US$/Kg)
Figure 6. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Region (2018-2029)
Figure 7. World Adeno-Associated Virus Vectors in Gene Therapy Production Market Share by Region (2018-2029)
Figure 8. North America Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029) & (Kg)
Figure 9. Europe Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029) & (Kg)
Figure 10. China Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029) & (Kg)
Figure 11. Japan Adeno-Associated Virus Vectors in Gene Therapy Production (2018-2029) & (Kg)
Figure 12. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 15. World Adeno-Associated Virus Vectors in Gene Therapy Consumption Market Share by Region (2018-2029)
Figure 16. United States Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 17. China Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 18. Europe Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 19. Japan Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 20. South Korea Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 21. ASEAN Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 22. India Adeno-Associated Virus Vectors in Gene Therapy Consumption (2018-2029) & (Kg)
Figure 23. Producer Shipments of Adeno-Associated Virus Vectors in Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adeno-Associated Virus Vectors in Gene Therapy Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adeno-Associated Virus Vectors in Gene Therapy Markets in 2022
Figure 26. United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adeno-Associated Virus Vectors in Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Market Share 2022
Figure 30. China Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Production Market Share 2022
Figure 32. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Type in 2022
Figure 34. Serotype 2 (AVV 2)
Figure 35. Synthetic Serotypes
Figure 36. Others
Figure 37. World Adeno-Associated Virus Vectors in Gene Therapy Production Market Share by Type (2018-2029)
Figure 38. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Type (2018-2029)
Figure 39. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Type (2018-2029) & (US$/Kg)
Figure 40. World Adeno-Associated Virus Vectors in Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Application in 2022
Figure 42. Alzheimer's Disease
Figure 43. Cystic Dibrosis
Figure 44. Hemophilia B
Figure 45. Parkinson's Disease
Figure 46. World Adeno-Associated Virus Vectors in Gene Therapy Production Market Share by Application (2018-2029)
Figure 47. World Adeno-Associated Virus Vectors in Gene Therapy Production Value Market Share by Application (2018-2029)
Figure 48. World Adeno-Associated Virus Vectors in Gene Therapy Average Price by Application (2018-2029) & (US$/Kg)
Figure 49. Adeno-Associated Virus Vectors in Gene Therapy Industry Chain
Figure 50. Adeno-Associated Virus Vectors in Gene Therapy Procurement Model
Figure 51. Adeno-Associated Virus Vectors in Gene Therapy Sales Model
Figure 52. Adeno-Associated Virus Vectors in Gene Therapy Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Related Reports
10 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
